Boston Scientific Stock Return On Equity
| BSX Stock | EUR 85.00 1.00 1.16% |
Boston Scientific fundamentals help investors to digest information that contributes to Boston Scientific's financial success or failures. It also enables traders to predict the movement of Boston Stock. The fundamental analysis module provides a way to measure Boston Scientific's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Boston Scientific stock.
Boston |
Boston Scientific Company Return On Equity Analysis
Boston Scientific's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Boston Scientific Return On Equity | 0.0408 |
Most of Boston Scientific's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Boston Scientific is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Boston Scientific has a Return On Equity of 0.0408. This is 100.17% lower than that of the Healthcare sector and 100.47% lower than that of the Medical Devices industry. The return on equity for all Germany stocks is 113.16% lower than that of the firm.
Boston Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Boston Scientific's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Boston Scientific could also be used in its relative valuation, which is a method of valuing Boston Scientific by comparing valuation metrics of similar companies.Boston Scientific is rated below average in return on equity category among its peers.
Boston Fundamentals
| Return On Equity | 0.0408 | |||
| Return On Asset | 0.0393 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 72.27 B | |||
| Shares Outstanding | 1.43 B | |||
| Shares Owned By Insiders | 0.20 % | |||
| Shares Owned By Institutions | 94.00 % | |||
| Price To Earning | 317.20 X | |||
| Price To Book | 3.80 X | |||
| Price To Sales | 4.91 X | |||
| Revenue | 12.68 B | |||
| Gross Profit | 8.68 B | |||
| EBITDA | 2.75 B | |||
| Net Income | 698 M | |||
| Cash And Equivalents | 2.68 B | |||
| Cash Per Share | 1.88 X | |||
| Total Debt | 8.91 B | |||
| Debt To Equity | 0.59 % | |||
| Current Ratio | 1.66 X | |||
| Book Value Per Share | 12.26 X | |||
| Cash Flow From Operations | 1.53 B | |||
| Earnings Per Share | 0.42 X | |||
| Price To Earnings To Growth | 2.51 X | |||
| Number Of Employees | 45 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 62.45 B | |||
| Total Asset | 32.47 B | |||
| Z Score | 4.2 | |||
| Net Asset | 32.47 B |
About Boston Scientific Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Boston Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Boston Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Boston Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.